Article Text

other Versions

Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis
  1. Lee-Wen Huang (m002057{at}
  1. Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital,, Taiwan
    1. Shiouh-Lirng Chao
    1. Department of Chinese Medicine, Renai Branch, Taipei City Hospital, Taiwan
      1. Bor-Heng Lee
      1. King Car Food Industrial Co., Ltd., Yuan Shan Research Institute, Ilan, Taiwan


        Aim: Human papillomavirus (HPV) integration is a critical event in cervical carcinogenesis. The aim of this study was to explore the physical status of HPV-16 and HPV-18 during the progression of cervical precancerous lesions. Methods: A series of 101 HPV-16 or HPV-18 positive cervical neoplasms (32 cervical intraepithelial neoplasia (CIN) and 69 cervical carcinomas (CC)) were evaluated. The physical status of both types of HPV was assessed from paraffin-embedded, formaldehyde-fixed surgical specimens by real-time polymerase chain reaction. Results: For HPV-16, integrated DNA was observed in 5 (83.3%) of 6 CIN I cases, 10 (90.9%) of 11 CIN II/III cases, 29 (82.9%) of 35 FIGO stage I CC cases and 16 (94.1%) of 17 FIGO stages II~IV CC cases. For HPV-18, integrated DNA was observed in 3 (50%) of 6 CIN I cases, 5 (55.6%) of 9 CIN II/III cases, 9 (64.3%) of 14 FIGO stage I CC cases and 1 (33.3%) of 3 FIGO stages II~IV CC cases. The mixed form of HPV DNA was the most prevalent physical state in both types of HPV. There was no significant difference between the physical state of HPV-16 and HPV-18 DNA with regard to the various grades of cervical lesions. Conclusions: These data imply that integration of HPV-16 and HPV-18 DNA into the host genomes occurs in the very early stage of cervical neoplastic progression. These early events may play an initiating role in the malignant transformation of HPV-16 and HPV-18 related low-grade lesions into high-grade dysplasia and invasive carcinoma.

        • Cervical carcinoma
        • Cervical dysplasia
        • Human papillomavirus (HPV)
        • Integration

        Statistics from

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.